Author Topic: (Abst.) Fingolimod effect on gray matter, thalamus and white matter in PwMS  (Read 143 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9670
  • MS diagnosed 1980
  • Location: Pacific Northwest

The researchers conclude that:

Fingolimod significantly reduced dGM volume loss (including thalamus) vs placebo in patients with RRMS. Reducing dGM and thalamic volume loss might improve long-term outcome.

From PubMed, March 16, 2018:
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.


Related Topics